Cargando…

In vitro and in vivo properties of a fully human IgG1 monoclonal antibody that combats multidrug resistant Pseudomonas aeruginosa

The development of an anti-bacterial drug in the form of a monoclonal antibody (mAb) targeting an exposed virulence factor, represents an innovative therapeutic strategy. Consequently, a fully human IgG1 mAb (LST-007) targeting Pseudomonas aeruginosa (PA) flagellin type b was recombinantly expressed...

Descripción completa

Detalles Bibliográficos
Autores principales:	ADAWI, AZMI, BISIGNANO, CARLO, GENOVESE, TIZIANA, FILOCAMO, ANGELA, KHOURI-ASSI, CAMELLIA, NEVILLE, ANAT, FEUERSTEIN, GIORA Z., CUZZOCREA, SALVATORE, NEVILLE, LEWIS F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2012
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573743/ https://www.ncbi.nlm.nih.gov/pubmed/22735858 http://dx.doi.org/10.3892/ijmm.2012.1040

Ejemplares similares

In Vitro Antimicrobial Activity and Effect on Biofilm Production of a White Grape Juice (Vitis vinifera) Extract
por: Filocamo, Angela, et al.
Publicado: (2015)

Fully Human Monoclonal Antibody Inhibitors of the Neonatal Fc Receptor Reduce Circulating IgG in Non-Human Primates
por: Nixon, Andrew E., et al.
Publicado: (2015)

Monoclonal Antibodies as Tools to Combat Fungal Infections
por: Ulrich, Sebastian, et al.
Publicado: (2020)

Combating physical inactivity during the COVID-19 pandemic
por: Pinto, Ana Jéssica, et al.
Publicado: (2020)

Almond Skin Inhibits HSV-2 Replication in Peripheral Blood Mononuclear Cells by Modulating the Cytokine Network
por: Arena, Adriana, et al.
Publicado: (2015)

Glomerulonephritis with monoclonal IgG deposits
por: Gandhi, K., et al.
Publicado: (2015)

ComBat Harmonization: Empirical Bayes versus fully Bayes approaches
por: Reynolds, Maxwell, et al.
Publicado: (2023)

Evaluation of Evolocumab (AMG 145), a Fully Human Anti‐PCSK9 IgG2 Monoclonal Antibody, in Subjects With Hepatic Impairment
por: Gibbs, John P., et al.
Publicado: (2016)

The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection
por: Mwangi, James, et al.
Publicado: (2019)

In vitro effect of bergamot (Citrus bergamia) juice against cagA-positive and-negative clinical isolates of Helicobacter pylori
por: Filocamo, Angela, et al.
Publicado: (2015)

Cellular distribution of monoclonal antibody in human tumours after i.v. administration.
por: Moshakis, V., et al.
Publicado: (1981)

Impact of IgG subclass on monoclonal antibody developability
por: Cain, Paul, et al.
Publicado: (2023)

Antibacterial activities of almond skins on cagA-positive and-negative clinical isolates of Helicobacter pylori
por: Bisignano, Carlo, et al.
Publicado: (2013)

Antiviral monoclonal antibody cocktails as a modern weapon in combating pandemics
por: Liu, Dingjiang, et al.
Publicado: (2021)

Combination of gallium(iii) with acetate for combating antibiotic resistant Pseudomonas aeruginosa
por: Wang, Yuchuan, et al.
Publicado: (2019)

Dual-action gallium-flavonoid compounds for combating Pseudomonas aeruginosa infection
por: He, Xiaojun, et al.
Publicado: (2023)

Study of Hole-Transporter-Free Perovskite Solar Cells based on Fully Printable Components
por: Raminafshar, Camellia, et al.
Publicado: (2019)

Combating acquired resistance to trastuzumab by an anti-ErbB2 fully human antibody
por: Wang, Chao, et al.
Publicado: (2017)

Editorial: Current perspectives on Pseudomonas aeruginosa: epidemiology, virulence and contemporary strategies to combat multidrug-resistant (MDR) pathogens
por: Behzadi, Payam, et al.
Publicado: (2022)

3,4-DHPEA-EA from Olea Europaea L. is effective against standard and clinical isolates of Staphylococcus sp.
por: Bisignano, Carlo, et al.
Publicado: (2014)

Focus on the Role of NLRP3 Inflammasome in Diseases
por: Fusco, Roberta, et al.
Publicado: (2020)

A Fully Human Inhibitory Monoclonal Antibody to the Wnt Receptor RYK
por: Halford, Michael M., et al.
Publicado: (2013)

Localization of human tumour xenografts after i.v. administration of radiolabeled monoclonal antibodies.
por: Moshakis, V., et al.
Publicado: (1981)

Detection and Characterization of Subvisible Aggregates of Monoclonal IgG in Serum
por: Filipe, Vasco, et al.
Publicado: (2012)

Impact of IgG subclass on molecular properties of monoclonal antibodies
por: Tang, Yu, et al.
Publicado: (2021)

Targeting the alternative sigma factor RpoN to combat virulence in Pseudomonas aeruginosa
por: Lloyd, Megan G., et al.
Publicado: (2017)

Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance
por: Liao, Chongbing, et al.
Publicado: (2022)

Absence of TLR4 Reduces Neurovascular Unit and Secondary Inflammatory Process after Traumatic Brain Injury in Mice
por: Ahmad, Akbar, et al.
Publicado: (2013)

Membranous nephropathy with monoclonal IgG4 deposits and associated IgG4-related lung disease
por: Omokawa, Ayumi, et al.
Publicado: (2014)

A fully caninised anti-NGF monoclonal antibody for pain relief in dogs
por: Gearing, David P, et al.
Publicado: (2013)

Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B
por: Matsumura, Takuhiro, et al.
Publicado: (2020)

Engineered Fully Human Single-Chain Monoclonal Antibodies to PIM2 Kinase
por: Kaewchim, Kanasap, et al.
Publicado: (2021)

Multifunctional Monoclonal Antibody Targeting Pseudomonas aeruginosa Keratitis in Mice
por: Hebert, Wesley, et al.
Publicado: (2020)

A rare case of crescentic glomerulonephritis with monoclonal IgG deposits
por: Ma, Xiaoyan, et al.
Publicado: (2021)

Rapid generation of a human monoclonal antibody to combat Middle East respiratory syndrome
por: Corti, Davide, et al.
Publicado: (2016)

Whole-Genome Sequence of Multidrug-Resistant Pseudomonas aeruginosa Strain BAMCPA07-48, Isolated from a Combat Injury Wound
por: Sanjar, Fatemeh, et al.
Publicado: (2016)

Structural Insights into the Neutralization Properties of the Fully Human, Anti-interferon Monoclonal Antibody Sifalimumab
por: Oganesyan, Vaheh, et al.
Publicado: (2015)

Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cells
por: Saha, Nayanendu, et al.
Publicado: (2023)

Development of an anti-Pseudomonas aeruginosa therapeutic monoclonal antibody WVDC-5244
por: Horspool, Alexander M., et al.
Publicado: (2023)

A Dual-Specificity Inhibitor Targets Polyphosphate Kinase 1 and 2 Enzymes To Attenuate Virulence of Pseudomonas aeruginosa
por: Neville, Nolan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bkab40gomerrsk1mtpf3665o1o